Evidence map›Paper›PMID 30159135›Full record

ArticleOncotarget2018

Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer.

Jung Ki Jo, Jong Jin Oh, Yong Tae Kim, Hong Sang Moon, Hong Yong Choi, Seunghyun Park, Jin-Nyoung Ho, Sungroh Yoon, Hae Young Park, Seok-Soo Byun

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jung Ki JoDepartment of Urology, Hanyang University Hospital, Seoul, Korea.
Jong Jin OhDepartment of Urology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Yong Tae KimDepartment of Urology, Hanyang University Hospital, Seoul, Korea.
Hong Sang MoonDepartment of Urology, Hanyang University Guri Hospital, Guri-si, Korea.
Hong Yong ChoiDepartment of Urology, Hanyang University Guri Hospital, Guri-si, Korea.
Seunghyun ParkDepartment of Electrical and Computer Engineering, Seoul National University, Seoul, Korea.
Jin-Nyoung HoBiomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Korea.
Sungroh YoonDepartment of Electrical and Computer Engineering, Seoul National University, Seoul, Korea.
Hae Young ParkDepartment of Urology, Hanyang University Hospital, Seoul, Korea.
Seok-Soo ByunDepartment of Urology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.18298.].

Identifiers

PMID30159135
PMCPMC6112751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.